Sou Hu Cai Jing·2025-08-12 02:57Core Viewpoint - The A-share market shows mixed performance, with the medical device ETF fund (159797) rising over 2% and attracting significant net subscriptions, indicating strong investor interest in the sector [1][4]. Group 1: Market Performance - The medical device ETF fund (159797) has seen a net subscription of 12 million units, marking its fifth consecutive day of substantial capital inflow [1]. - Notable stocks in the brain-computer interface sector have experienced significant gains, with Sanxin Medical hitting a 20% limit up and other companies like Sainuo Medical and Lepu Medical also showing strong performance [1][4]. Group 2: Policy and Industry Trends - On August 7, a joint announcement from seven departments outlined plans to promote the brain-computer interface industry, setting development goals for 2027 and 2030, and detailing five key tasks and 17 specific measures [3]. - Citic Securities highlighted a shift in policy towards supporting innovative medical devices, suggesting that the medical device sector's valuation and performance are likely to recover [4]. Group 3: Company Highlights - Sainuo Medical achieved three 20% limit up days within four trading days, following the FDA's breakthrough designation for its intracranial drug-coated stent system, marking a significant milestone in the industry [4]. - Sanxin Medical reported a revenue of 761 million yuan for the first half of 2025, a year-on-year increase of 10.83%, and a net profit of 115 million yuan, up 8.35% from the previous year [4]. Group 4: Investment Outlook - Analysts believe the medical device sector is at a turning point, with expectations of improved performance in Q3 as companies recover from inventory pressures and benefit from policy optimizations [5]. - The international business of several medical device companies is growing rapidly, with some companies reporting that international revenue accounts for nearly or over 50% of their total income [5][6].